Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis

Registry ID

EUCTR2012-004845-34

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Sanofi-aventis recherche et développement

Start date

2013-07-03

Completion date

2016-04-19

Last update

2026-08-16

Conditions

• Uveitis

Summary

To evaluate the efficacy of sarilumab at week 16 in patients with non-infectious uveitis (NIU).

Locations

• , , Italy
• , , Czechia
• , , Germany
• , , Spain

Related clinical trials

• A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.
• Metagenomics for Ocular Inflammation
• A Study of Uveitis in Children <18 Years of Age
• RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
• Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
• Genetics of Uveitis

View on source registry